Ph2 ZN-c3 Uterine Carcinoma

Phase II Clinical Trial

A Phase 2 Open-Label Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma (ZN-c3-004 GOG 3065)

Indication: Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Uterine Cancer, Uterine Cancer, Uterine Cancer
Trial Number: 04814108
Trial Status: Call Proj Mgr

Learn more about this clinical trial.

Participating Locations